About UMGCCC's NCI Designation
Connecting you to one of the nation's best cancer centers.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) – the hub of the University of Maryland Cancer Network -- has achieved the National Cancer Institute’s highest designation as a Comprehensive Cancer Center. This prestigious distinction recognizes the center’s robust research program, high caliber of scientific leadership and, most importantly, the progress we are making in fighting and preventing cancer.
So, what does this mean for cancer patients throughout Maryland?
It means that by getting your care at your local community hospital within the UM Cancer Network -- UM Baltimore Washington Medical Center’s Tate Cancer Center, UM St. Joseph Medical Center’s The Cancer Institute or UM Upper Chesapeake Health’s Patricia D. and M. Scot Kaufman Cancer Center -- you are connected to the national experts, leading edge technology and clinical trials offered by the UM Greenebaum Comprehensive Cancer Center – now recognized as one of the nation’s best.
We are proud that the UM Greenebaum Comprehensive Cancer Center has earned this new distinction. It is a testament to the quality of its physicians and researchers, and it impacts the care that the UM Cancer Network can offer patients.
Learn more about the UM Greenebaum Comprehensive Cancer Center’s new designation at umgccc.org.